Pharmacogenetics in the Toronto Star: "When the Cure is the Problem"

Six Questions Benefit Providers Should Ask Their PGx Partner

Click here to read "Six Questions Benefit Providers Should Ask Their PGx Partner"

Inagene Diagnostics Inc.’s CEO featured alongside global expert advocates highlighting pharmacogenomic (gene-drug compatibility) testing as a game-changing innovation to safeguard the health of Canadians

Click here to read the article on the GlobeNewswire website

Inagene Diagnostics Inc. and Granville Biomedical Inc. team up to provide locally-produced pharmacogenetic testing kits to Canadians

Click here to read the article on the GlobeNewswire website

Pharmacogenetic testing uses DNA to predict patients’ responses to medications

Click here to read the article on the Globe and Mail website

September's International Pain Awareness Month marks critical moment to leverage more effective methods of treating chronic pain…

Click here to read the article on the Financial Post website

Canada's surgery backlog could lead to wave of new chronic pain and opioid dependencies According to Inagene Diagnostics Inc., genetic testing can help mitigate the risk of chronic pain and reliance on medications

Click here to read the article on the Financial Post website

Canadians living with mental health conditions stand to save over $57 billion with use of pharmacogenetic testing…

Click here to read the article on the Financial Post website

Inagene Pharmacogenetic Testing Featured on Global News

Click here to watch the Global News segment featuring Inagene Pharmacogenetic Testing